comprehensive -WSS

comprehensive

author：leisure time 2025-10-01 10:35:45 - browse：5494

The Blue Shield of California headquarters building is seen in San Francisco – health care policy from STAT — Eric Risberg/AP

Two dominant Blue Cross Blue Shield companies in California intentionally underreported premiums of certain health plans so they could avoid paying Affordable Care Act taxes, according to new federal whistleblower complaints.

These claims renew concerns about whether health insurance companies have skirted the tax code and to what extent tax fraud could exist in the industry.

Blue Shield of California evaded $111 million in taxes between 2016 and 2020, according to a complaint that was filed with the Internal Revenue Service on June 27. Elevance Health, the parent company of Anthem Blue Cross in California, evaded $60 million in taxes during the same time period, according to a separate complaint filed with the IRS.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

Wikipedia

leisure time

WSS

Lasker Awards 2023: Winners in biomedical research

It's been 20 years since Dolly the sheep. Where's my clone?

Peter Marks talks Operation Warp Speed for Rare Diseases

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

CDC advisers recommend seasonal use of Pfizer RSV shot

Nick Jonas talks about managing diabetes along with his career

explore

comprehensive

hotspot

Supreme Court strikes down use of affirmative action

Nick Jonas talks about managing diabetes along with his career

BioMarin wins approval for gene therapy to treat hemophilia A

FDA panel to weigh approval of NurOwn, controversial ALS drug

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Life sciences deals on track to hit lowest point since 2017

Anesthesiologist group: stop taking Ozempic before surgery

Readout LOUD podcast: possible new ALS drug, artificial wombs

Jerome Adams on the need for new antivirals for Covid

Humana CEO Bruce Broussard to step down in 2024

Wikipedia

Drug for rare kidney disease narrowly misses mark in clinical trial

Second xenotransplant done with gene

European regulators recommend Amylyx's ALS drug be rejected

STAT Readout: Today's biotech news includes Sana and Amylyx

How clinical AI models' predictive power can degrade over time

Eight reasons why you should get an updated Covid vaccine

Wikipedia

knowledge

leisure time

knowledge